Cargando…
Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report
RATIONALE: Antiphospholipid syndrome (APS) in pregnancy may trigger the life-threatening catastrophic antiphospholipid syndrome (CAPS). Complement activation is implicated in the pathogenesis, and inhibition of complement factor C5 is suggested as an additional treatment option. PATIENT CONCERNS, DI...
Autores principales: | Gustavsen, Alice, Skattum, Lillemor, Bergseth, Grethe, Lorentzen, Bjorg, Floisand, Yngvar, Bosnes, Vidar, Mollnes, Tom Eirik, Barratt-Due, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369917/ https://www.ncbi.nlm.nih.gov/pubmed/28296762 http://dx.doi.org/10.1097/MD.0000000000006338 |
Ejemplares similares
-
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
por: Barratt-Due, Andreas, et al.
Publicado: (2016) -
Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report
por: Kronbichler, Andreas, et al.
Publicado: (2014) -
Clinical and Complement Long-Term Follow-Up of a Pediatric Patient with C3 Mutation-Related Atypical Hemolytic Uremic Syndrome
por: Bjerre, Anna, et al.
Publicado: (2018) -
Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review
por: Fukui, Shoichi, et al.
Publicado: (2015) -
Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review
por: Garra, Wakar, et al.
Publicado: (2023)